ID
23246
Beschrijving
Responsible Party: Dominik Bettinger, investigator, University Hospital Freiburg ClinicalTrials.gov Identifier: NCT01360255 History of Changes Other Study ID Numbers: HCC2 DRKS00000812 ( Registry Identifier: German Clinical Trials Register ) Study First Received: May 9, 2011 Last Updated: December 14, 2011 AFP- L3% and DCP as Tumor Markers in Patients With Hepatocellular Carcinoma (HCC) Treated With Transarterial Chemoembolisation (TACE) ODM derived from: https://clinicaltrials.gov/ct2/show/NCT01360255
Link
https://clinicaltrials.gov/ct2/show/NCT01360255
Trefwoorden
Versies (1)
- 30-06-17 30-06-17 -
Geüploaded op
30 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Hepatocellular Carcinoma DRKS00000812 NCT01360255 DRKS00000812
Eligibility Hepatocellular Carcinoma NCT01360255 DRKS00000812
- StudyEvent: ODM
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI-1
- C0680251
Beschrijving
Control Group
Datatype
boolean
Alias
- UMLS CUI [1]
- C0009932
Beschrijving
Liver tumor of unknown origin
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C2239176
- UMLS CUI [1,2]
- C0346426
Beschrijving
Other liver tumors
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0205394
- UMLS CUI [1,2]
- C2239176
Beschrijving
Contraindication to TACE
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3539919
- UMLS CUI [1,2]
- C1301624
Similar models
Eligibility Hepatocellular Carcinoma NCT01360255 DRKS00000812
- StudyEvent: ODM
C1301732 (UMLS CUI [1,2])
C0346426 (UMLS CUI [1,2])
C2239176 (UMLS CUI [1,2])
C1301624 (UMLS CUI [1,2])